NCT05550077 Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
| NCT ID | NCT05550077 |
| Status | Recruiting |
| Phase | — |
| Sponsor | jiaoliqun |
| Condition | Intracranial Atherosclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2020-03-15 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2020-03-15 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the clinical significance of optical coherence tomography (OCT) in interventional treatment of intracranial atherosclerotic stenosis (ICAS).
Eligibility Criteria
Inclusion Criteria: * Symptomatic ICAS. Participants with ICAS with a transient ischaemic attack (TIA) or stroke attributable to the territory of the stenotic artery were defined as symptomatic. A TIA was defined as a transient episode of neurological dysfunction (focal weakness or language disturbance, transient monocular blindness, or required assistance in walking) caused by focal brain or retinal ischaemia that lasted for at least 10 minutes but resolved within 24 hours * Stenotic degree ≥ 50%, measured by digital subtraction angiography * The stenosis must located in at least one major intracranial artery (internal carotid artery, vertebral artery, middle cerebral artery, or basilar artery) Exclusion Criteria: * Arteriovenous Malformation * Aneurysm
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05550077 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intracranial Atherosclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05550077 currently recruiting?
Yes, NCT05550077 is actively recruiting participants. Contact the research team at liqunjiao@sina.cn for enrollment information.
Where is the NCT05550077 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05550077 clinical trial?
NCT05550077 is sponsored by jiaoliqun. The trial plans to enroll 400 participants.